홈 › 흑색종 › 캘리포니아 › Los Angeles
CA Los Angeles의 흑색종 임상 시험
흑색종 관련 연구 34개가 Los Angeles 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
피험자 모집 중1/2상
- The Angeles Clinic and Research Institute (Melanoma), Los Angeles
- USC Norris Comprehensive Cancer Center (Melanoma/NSCLC), Los Angeles
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
피험자 모집 중3상
- University of California Los Angeles, Los Angeles
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
피험자 모집 중2상
- The Angeles Clinic and Research Institute - West Los Angeles Office, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
- 외 1개
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
피험자 모집 중1/2상
- University of Southern California, Los Angeles
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
피험자 모집 중3상
- USC Norris Comprehensive Cancer Center, Los Angeles
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
피험자 모집 중3상
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Intratumoral N17350 in Advanced Solid Tumors
피험자 모집 중1/2상
- The Angeles Clinic and Research Institute, Los Angeles
- UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
피험자 모집 중2상
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
피험자 모집 중1/2상
- START Los Angeles, Los Angeles
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
피험자 모집 중1상
- The Angeles Clinic, Los Angeles
- UCLA, Los Angeles
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
피험자 모집 중1/2상
- Keck Medicine of USC Koreatown, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Project: Every Child for Younger Patients With Cancer
피험자 모집 중관찰 연구
- Children's Hospital Los Angeles, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
- Mattel Children's Hospital UCLA, Los Angeles
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
피험자 모집 중1/2상
- Children's Hospital Los Angeles, Los Angeles
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- USC/Norris Comprehensive Cancer Center, Los Angeles
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
피험자 모집 중1/2상
- The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
피험자 모집 중1상
- The Angeles Clinic and Research Institute, Los Angeles
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
피험자 모집 중1상
- START Los Angeles, Los Angeles
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
피험자 모집 중1/2상
- Los Angeles Cancer Network, Los Angeles
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
피험자 모집 중1/2상
- California Research Institute, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
The Multicentre Selective Lymphadenectomy Trial - 3
피험자 모집 중
- Cedars-Sinai Medical Centre, Los Angeles
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
피험자 모집 중1/2상
- The Angeles Clinic and Research Institute, Los Angeles
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
피험자 모집 중1/2상
- UCLA Medical Center, Los Angeles
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
피험자 모집 중2상
- USA06-0, Los Angeles
- USA16-0, Los Angeles
Neoadjuvant Darovasertib in Primary Uveal Melanoma
피험자 모집 중3상
- Jules Stein Eye Institute, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
피험자 모집 중
- Oncology Institute for Hope and Innovation, Los Angeles
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
피험자 모집 중1/2상
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study of VET3-TGI in Patients With Solid Tumors
피험자 모집 중1상
- USC/Norris Comprehensive Cancer Center, Los Angeles
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
피험자 모집 중2/3상
- The Angeles Clinic and Research Institute, Los Angeles
- University of California Los Angeles, Los Angeles
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
피험자 모집 중1상
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma
피험자 모집 중2상
- The Angeles Clinic at Cedars Sinai, Los Angeles
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
피험자 모집 중1/2상
- Research Site 125, Los Angeles
- Research Site 133, Los Angeles
- Research Site 103, Los Angeles
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- UCLA Health, Los Angeles
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
피험자 모집 중1/2상
- The Angeles Clinic and Research Institute, Los Angeles
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
피험자 모집 중
- Los Angeles General Medical Center, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
- 외 2개
다른 도시의 흑색종 시험
- Houston, TX연구 59개
- New York City, NY연구 38개
- Nashville, TN연구 33개
- Pittsburgh, PA연구 31개
- Boston, MA연구 26개
- Philadelphia, PA연구 23개
- San Francisco, CA연구 22개
- St. Louis, MO연구 21개
- Durham, NC연구 21개
- Columbus, OH연구 21개
- Atlanta, GA연구 21개
- Salt Lake City, UT연구 21개
Los Angeles의 다른 연구
- 비소세포폐암연구 87개
- 암 (전체)연구 74개
- 유방암연구 73개
- 전립선암연구 61개
- 대장직장암연구 59개
- 전이성 암연구 57개
- 난소암연구 50개
- 폐암연구 45개
- 두경부 편평세포암연구 42개
- 췌장암연구 35개
- 자궁내막암연구 34개
- 삼중음성 유방암연구 27개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.